Recombinant transaminase as well as preparation method and application of recombinant transaminase
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU ALPHA PHARM CO LTD
- Publication Date
- 2017-06-06
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of bioengineering, and in particular relates to a recombinant transaminase and its preparation method and application. Background technique
[0002] Diabetes is a systemic chronic progressive disease caused by the body's own metabolic disorder, which is caused by insufficient insulin secretion or insulin action disorder. Diabetes is usually accompanied by complications such as coronary heart disease, cerebrovascular disease, nephropathy, and necrosis of lower extremities. It is a complex and frequently-occurring disease. At present, the number of adults with diabetes in the world is 422 million, and it is estimated that by 2025, more than 700 million people worldwide will suffer from diabetes.
[0003] Diabetes is mainly divided into type Ⅰ and type Ⅱ. Type Ⅱ diabetes is non-insulin-dependent diabetes, which is caused by insulin resistance or impaired function of pancreatic β cells. Its patients account for...